Paul Sallwasser Sells 5,140 Shares of Youngevity International Inc (NASDAQ:YGYI) Stock
Youngevity International Inc (NASDAQ:YGYI) Director Paul Sallwasser sold 5,140 shares of Youngevity International stock in a transaction dated Friday, June 7th. The stock was sold at an average price of $5.04, for a total value of $25,905.60. Following the transaction, the director now directly owns 62,853 shares in the company, valued at $316,779.12. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website.
YGYI traded up $0.12 during midday trading on Wednesday, hitting $5.13. 2,528 shares of the company were exchanged, compared to its average volume of 161,372. Youngevity International Inc has a 1-year low of $3.17 and a 1-year high of $16.25. The company has a quick ratio of 0.49, a current ratio of 1.16 and a debt-to-equity ratio of 0.53.
Youngevity International (NASDAQ:YGYI) last announced its earnings results on Tuesday, April 16th. The company reported ($0.46) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.06) by ($0.40). The company had revenue of $36.11 million for the quarter. Youngevity International had a negative return on equity of 125.30% and a negative net margin of 17.08%.
Separately, Benchmark lifted their target price on Youngevity International from $9.00 to $14.00 and gave the stock a “buy” rating in a report on Wednesday, February 13th.
About Youngevity International
Youngevity International, Inc develops and distributes health and nutrition related products and services through independent direct selling network in the United States and internationally. It operates in two segments, Direct Selling and Commercial Coffee. The company offers approximately 5,500 products, including nutritional, vitamin, mineral, herbal, liquid, and dietary supplements; apparel; fashion and jewelry accessories; digital products; and packaged foods.
Featured Story: Gap Up Stocks
Receive News & Ratings for Youngevity International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Youngevity International and related companies with MarketBeat.com's FREE daily email newsletter.